Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print August 2, 2006, doi:10.1212/01.wnl.0000229927.12007.37)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000229927.12007.37v1
67/5/872    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carpentier, C.
Right arrow Articles by Sanson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carpentier, C.
Right arrow Articles by Sanson, M.
Related Collections
Right arrow All Oncology
Right arrow Primary brain tumor
Right arrow Association studies in genetics
NEUROLOGY 2006;67:872-874
© 2006 American Academy of Neurology
Brief Communications

Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma

C. Carpentier, MSc, F. Laigle-Donadey, MD, Y. Marie, MSc, N. Auger, MD, A. Benouaich-Amiel, MD, J. Lejeune, MSc, G. Kaloshi, MD, J. -Y. Delattre, MD, J. Thillet, PhD and M. Sanson, MD, PhD

From INSERM U711 (C.C., Y.M., N.A., A.B.-A., J.-Y.D., J.T., M.S.), Biologie des Interactions Neurones and Glie, Université Pierre et Marie Curie, Faculté de Médecine, and Groupe Hospitalier Pitié-Salpêtrière, and Service de Neurologie Mazarin (F.L.-D., A.B.-A., J.L., G.K., Y.-Y.D., M.S.), Hôpital de la Salpêtrière, Paris, France.

Address correspondence and reprint requests to Dr. M. Sanson, Service de Neurologie Mazarin, Groupe Hospitalier Pitié-Salpêtrière, 47 boulevard de l’Hôpital, 75013 Paris, France; e-mail: marc.sanson{at}psl.ap-hop-paris.fr

We investigated two polymorphisms of the epidermal growth factor receptor promoter as potential risk factors and prognostic markers for glioblastoma. The –216T allele (which results in a 30% higher activity) was more frequent in the patients compared with the control population (224/376 = 59.6% vs 165/352 = 46.8%; p = 0.0006) corresponding to an odd ratio of 1.67 (1.24; 2.25). A modest difference in median survival was also associated with the TT genotype.

This article was previously published in electronic format as an Expedited E-Pub on August 2, 2006, at www.neurology.org.

Supported by the Délégation à la Recherche Clinique (AP-HP; grant no. MUL 03012) and the Ligue Nationale contre le Cancer, comité d’Ille et Vilaine.

Disclosure: The authors report no conflicts of interest.

Received November 30, 2005. Accepted in final form April 24, 2006.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
W.-S. Wang, P.-M. Chen, T.-J. Chiou, J.-H. Liu, J.-K. Lin, T.-C. Lin, H.-S. Wang, and Y. Su
Epidermal Growth Factor Receptor R497K Polymorphism Is a Favorable Prognostic Factor for Patients with Colorectal Carcinoma
Clin. Cancer Res., June 15, 2007; 13(12): 3597 - 3604.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.